CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 142 enrolled
Drug / intervention
Esketamine +1 moredrug
Likely dose
Esketamine 0.3mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06608030
NCT06608030N/ACompleted

Effect of a Single Dose of Esketamine on Perioperative Negative Mood in Patients Undergoing Cardiac Valve Surgery: a Randomized Controlled Trial

Chinese PLA General Hospital·interventional·Posted Sep 23, 2024·Updated Nov 25, 2025

In Brief

A clinical study evaluating Esketamine and normal saline for Depression, Anxiety and 2 related conditions. Completed, enrolled 142 participants across 2 sites.

Detailed Summary

A multicenter, randomized controlled, blinded prospective study to investigate the effects of esketamine on perioperative anxiety and depression in patients undergoing cardiac valve surgery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesChina

Timeline

N/ACompletedFinished
20252026
First PostedSep 23, 2024
Enrollment StartSep 23, 2024
Primary CompletionApr 7, 2025
Study CompletionApr 30, 2025
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 1.8 years ago

Interventions

Esketaminedrug

A single dose of 0.3mg / kg esketamine during induction of anesthesia.

normal salinedrug

Receiving the same volume of normal saline during induction of anesthesia.